文献速递结核与非结核分枝杆菌

痰液蛋白质组MALDI-TOF MS鉴别肺结核与非结核的初步研究

Sputum proteomic analysis for distinguishing between pulmonary tuberculosis and non-tuberculosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): preliminary results.
PubMed 文献 · Clin Microbiol Infect · 2021-03-09

本研究评估痰液MALDI-TOF MS蛋白质谱诊断肺结核的可行性。102例疑似肺结核患者分为确诊PTB 35例、非结核下呼吸道感染36例和非结核对照31例。模型区分PTB与非结核对照灵敏度97%、特异度77%;区分PTB与非结核LRTI灵敏度80%、特异度89%。

要点

  • 痰液MALDI-TOF MS蛋白质谱可用于筛查肺结核。
  • 区分PTB与非结核对照灵敏度97%,特异度77%。
  • 区分PTB与非结核LRTI灵敏度80%,特异度89%。

核心结论

  • 痰液MALDI-TOF MS蛋白质谱分析联合镜检可作为诊断肺结核的筛查工具。

研究设计与样本

  • 研究纳入102例疑似肺结核患者,包括确诊PTB 35例、非结核LRTI 36例和非结核对照31例,采用MALDI-TOF MS分析痰液蛋白质谱。

主要发现

  • 使用25个差异表达蛋白峰区分PTB与非结核对照,灵敏度97%(95%CI 85-100%),特异度77%(95%CI 59-90%)。
  • 使用10个差异表达蛋白峰区分PTB与非结核LRTI,灵敏度80%(95%CI 63-92%),特异度89%(95%CI 74-97%)。
  • 非结核对照中,MALDI-TOF MS痰分析的阴性预测值为96%(95%CI 80-100%),高于直接痰涂片镜检和痰培养的78%(95%CI 62-89%)。
  • MALDI-TOF MS痰分析联合直接镜检时,非结核LRTI患者的阴性预测值达94%(95%CI 80-99%)。

临床怎么用

  • 对疑似肺结核患者,可考虑痰液MALDI-TOF MS蛋白质谱分析联合镜检进行筛查。
  • 高阴性预测值有助于排除非结核患者,但需结合临床和其他检查综合判断。

局限性

  • 本研究为初步结果,样本量有限,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim was to evaluate the feasibility and diagnostic contribution of protein profiling using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) applied to sputum to diagnose pulmonary tuberculosis. METHODS: Sputum samples collected from patients suspected of having pulmonary tuberculosis were analysed using MALDI-TOF MS. Using the differentially expressed protein peaks, we compared three groups of patients, including those with confirmed pulmonary tuberculosis (PTB), those without tuberculosis but with a lower respiratory tract infection (non-TB LRTI) and those without tuberculosis and without an LRTI (non-TB controls). RESULTS: A total of 102 patients included 35 PTB, 36 non-TB LRTI and 31 non-TB controls. The model differentiated between the PTB patients and the non-TB controls using the 25 most differentially expressed protein peaks, with a sensitivity of 97%, 95% CI 85-100%, and a specificity of 77%, 95% CI 59-90%. The model distinguished the PTB patients from the non-TB LRTI patients using the ten most differentially expressed protein peaks, with a sensitivity of 80%, 95% CI 63-92%, and a specificity of 89%, 95% CI 74-97%. We observed that the negative predictive value of MALDI-TOF MS sputum analysis was higher (96%, 95% CI 80-100%) than that of direct sputum microscopic examination and sputum culture (78%, 95% CI 62-89%) for non-TB controls. When MALDI-TOF MS sputum analysis and direct microscopic examination were combined, the negative predictive value reached 94%, 95% CI 80-99%, for non-TB LRTI patients. DISCUSSION: These results suggest that MALDI-TOF MS sputum analysis coupled with microscopic examination could be used as a screening tool for diagnosing pulmonary TB.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Dao TL, Hoang VT, Ly TDA, et al. Sputum proteomic analysis for distinguishing between pulmonary tuberculosis and non-tuberculosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): preliminary results. Clin Microbiol Infect. 2021. PMID: 33711448. doi:10.1016/j.cmi.2021.02.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。